TuHURA BIOSCIENCES, INC./NV Depreciation and Amortization
TuHURA BIOSCIENCES, INC./NV (HURA) reported Depreciation and Amortization of $51.58 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV depreciation, depletion and amortization for the quarter ending 2026-06-30 was $28.10K, a 110.19% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV depreciation, depletion and amortization for the quarter ending 2026-03-31 was $23.47K, a 66.97% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV depreciation, depletion and amortization for the quarter ending 2025-12-31 was $22.54K, a 27.84% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV depreciation, depletion and amortization for the quarter ending 2025-09-30 was $21.29K, a 26.93% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV depreciation, depletion and amortization for fiscal 2025 was $71.27K, a 38.94% decline from fiscal 2024.
- TuHURA BIOSCIENCES, INC./NV depreciation, depletion and amortization for fiscal 2024 was $116.71K, a 34.20% decline from fiscal 2023.
- TuHURA BIOSCIENCES, INC./NV depreciation, depletion and amortization for fiscal 2023 was $177.38K.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $51.58K 10-Q · filed 2026-08-14 | $74.12K derived: sum of 3 quarters · filed 2026-08-14 | $95.41K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $23.47K 10-Q · filed 2026-05-15 | $46.02K derived: sum of 2 quarters · filed 2026-05-15 | $67.31K derived: sum of 3 quarters · filed 2026-05-15 | $80.68K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $22.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $43.84K derived: sum of 2 quarters · filed 2026-03-31 | $57.21K derived: sum of 3 quarters · filed 2026-08-14 | $71.27K 10-K · filed 2026-03-31 |
| 2025-09-30 | $21.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $34.66K derived: sum of 2 quarters · filed 2026-08-14 | $48.72K 10-Q · filed 2025-11-14 | $66.36K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $13.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $27.43K 10-Q · filed 2026-08-14 | $45.06K derived: sum of 3 quarters · filed 2026-08-14 | $74.20K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $14.06K 10-Q · filed 2026-05-15 | $31.69K derived: sum of 2 quarters · filed 2026-05-15 | $60.83K derived: sum of 3 quarters · filed 2026-05-15 | $96.46K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $17.64K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $46.78K derived: sum of 2 quarters · filed 2026-03-31 | $82.40K derived: sum of 3 quarters · filed 2026-03-31 | $116.71K 10-K · filed 2026-03-31 |
| 2024-09-30 | $29.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $64.77K derived: sum of 2 quarters · filed 2025-11-14 | $99.08K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $35.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $69.93K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $34.31K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $177.38K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |